BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guevarra JT, Hiensch R, Varga AW, Rapoport DM. Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility. Nat Sci Sleep 2020;12:709-19. [PMID: 33117007 DOI: 10.2147/NSS.S264140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sarfraz N, Okuampa D, Hansen H, Alvarez M, Cornett EM, Kakazu J, Kaye AM, Kaye AD. pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy. Health Psychology Research 2022;10. [DOI: 10.52965/001c.34222] [Reference Citation Analysis]
2 Ishikawa O, Hahn S, Greenberg H; Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA. Pharmacologic Therapy for Narcolepsy. Neurology 2022;18:68. [DOI: 10.17925/usn.2022.18.1.68] [Reference Citation Analysis]
3 Sarasola MP, Táquez Delgado MA, Nicoud MB, Medina VA. Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacol Res Perspect 2021;9:e00778. [PMID: 34609067 DOI: 10.1002/prp2.778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]